[email protected]12 Jan, 2022News
The latest Tweet by IANS India states, 'Homegrown Emcure Pharmaceuticals Ltd on Friday announced that it has received Emergency Use Authorisation approval for the launch of #Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild #COVID19.' Homegrown Emcure Pharmaceuticals Ltd on Friday announced that it has received Emergency Use Authorisation (EUA) approval for the launch of #Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild #COVID19.
Network Right
Hay88 Feedback
Pratik Jain
Robertmygardenandpatio
Mpo2121
Modus Accountants
Luck8 Điều Hướng Trang Web
Sunwin ⭐️ Link Trang Chủ Sunwin
Kubet
Fhp Group